GlassScriptPhysician profile
Lindsey N Johnson
NPI 1912696550
$3,253.76
in general payments reported to CMS, 2019-2025
23 companies · $2,984 in 2025
The $2,984 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $270 · 2025: $2,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,188 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,187.77 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $408.25 | 2025 | |
| Galderma Laboratories, L.P. | $346.29 | 2025 | Nemluvio |
| Incyte Corporation | $322.45 | 2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $305.15 | 2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $296.84 | 2025 | Anzupgo, Adbry |
| Organon LLC | $273.40 | 2025 | Vtama |
| Astrazeneca Pharmaceuticals LP | $269.99 | 2024 | Airsupra, Farxiga |
| Regeneron Healthcare Solutions, INC. | $152.79 | 2025 | Dupixent |
| Kyowa Kirin, INC. | $148.59 | 2025 | |
| Botanix Sb INC | $129.62 | 2025 | Sofdra |
| Ucb, INC. | $101.78 | 2025 | Bimzelx |
| Genzyme Corporation | $99.80 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $80.21 | 2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $78.22 | 2025 | |
| Janssen Biotech, INC. | $57.11 | 2025 | Tremfya |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.18 | 2025 | |
| Organogenesis INC. | $29.68 | 2025 | Puraply Wound Matrix |
| Amgen INC. | $29.04 | 2025 | Otezla |
| Biowound Solutions, INC. | $24.51 | 2025 | Bio-Connekt |
| Lnhc, INC | $19.20 | 2025 | Zelsuvmi |
| Genentech USA, INC. | $18.11 | 2025 | Xolair |
| Almirall LLC | $15.51 | 2025 | Klisyri |
| Arcutis Biotherapeutics, INC. | $14.04 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.